For US Healthcare Providers Only

For US Healthcare Providers Only

Hello world!

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

TOP

IMPORTANT SAFETY INFORMATION

Indication

Makena is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history

Important Safety Information for Makena
(hydroxyprogesterone caproate injection)

  • Do not use Makena in women with any of the following conditions:

You are now leaving makenahcp.com. AMAG Pharmaceuticals is not responsible for the information contained in any of the linked third-party sites. Please review the site's Privacy Policy and Terms of Use, as AMAG's policies do not apply to third-party sites.

Cancel Continue

You are now leaving makenahcp.com. AMAG Pharmaceuticals is not responsible for the information contained in any of the linked third-party sites. Please review the site's Privacy Policy and Terms of Use, as AMAG's policies do not apply to third-party sites.

Cancel Continue

We acknowledge there is disruption in the healthcare community as you work through the rapidly evolving guidelines from the CDC in response to the COVID-19 pandemic. Our team at Makena Care Connection remains available to support your office and your patients.

If you have concerns of therapy disruptions for your patients, please call Makena Care Connection. Your Care Manager can discuss options such as changing the shipping location, exploring home healthcare administration, or troubleshooting any potential shipping delays. Makena Care Connection can be reached at 1-800-847-3418 or info@makenacareconnection.com from Monday–Friday 8:00 AM–8:00 PM ET.

If you are incorporating telemedicine into your practice, consider visiting our Resources page to learn about our online prescribing option and to download a Telemedicine Toolkit, containing prescribing resources and materials for your patients.

©2020 AMAG Pharmaceuticals, Inc. All rights reserved. PP-MKN-US-00612 04/20